| Overall (n = 202) | Controls (n = 108) | T2D(n = 94) | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | |
Age, years | 1.01 | 1.00–1.04 | 0.14 | 1.03 | 1.00–1.05 | 0.04 | 0.99 | 0.96–1.03 | 0.67 |
Male sex | 1.91 | 1.06–3.45 | 0.03 | 1.78 | 0.83–3.90 | 0.14 | 2.35 | 0.93–6.38 | 0.07 |
BMI, kg/m2 | 1.01 | 0.95–1.07 | 0.78 | 0.97 | 0.89–1.04 | 0.40 | 1.08 | 0.99–1.19 | 0.09 |
Dyslipidemia | 2.33 | 1.32–4.12 | 0.003 | 1.93 | 0.85–4.48 | 0.12 | 3.75 | 1.57–9.50 | 0.003 |
CATi, mL/m2 (continuous) | 1.005 | 1.0003–1.01 | 0.03 | 1.00 | 0.99–1.01 | 0.99 | 1.01 | 1.00–1.02 | 0.001 |
CATi > 100 mL/m2 (dichotomous) | 1.52 | 0.87–2.67 | 0.15 | 0.73 | 0.34–1.57 | 0.42 | 4.71 | 1.78–12.49 | 0.002 |
VATi, mL/m2 | 1.00 | 1.00–1.00 | 0.24 | 1.00 | 1.00–1.00 | 0.94 | 1.001 | 1.00–1.002 | 0.046 |
SATi, mL/m2 | 1.00 | 1.00–1.00 | 0.64 | 1.00 | 1.00–1.00 | 0.30 | 1.00 | 1.00–1.00 | 0.61 |
Severe lung lesions (> 50%) | 1.64 | 0.75–3.69 | 0.22 | 1.17 | 0.38–3.81 | 0.78 | 1.21 | 0.43–3.59 | 0.73 |
CAC DRS = 3 | 1.30 | 0.62–2.74 | 0.48 | 3.49 | 0.9–14 | 0.06 | 0.83 | 0.32–2.17 | 0.70 |
Leukocytes, × 109/L | 1.08 | 0.99–1.18 | 0.09 | 1.11 | 0.98–1.28 | 0.09 | 1.05 | 0.94–1.19 | 0.38 |
eGFR, mL/min/1.73 m2 | 0.99 | 0.99–1.00 | 0.14 | 0.99 | 0.98–1.00 | 0.23 | 0.99 | 0.98–1.00 | 0.26 |
CRP, mg/L | 1.005 | 1.001–1.008 | 0.007 | 1.00 | 1.00–1.01 | 0.06 | 1.01 | 1.00–1.01 | 0.045 |
Troponin-T, ng/L | 1.00 | 1.00–1.01 | 0.10 | 1.01 | 1.00–1.02 | 0.09 | 1.00 | 1.00–1.01 | 0.42 |
Glycemia, mL | 1.05 | 0.96–1.14 | 0.27 | 1.29 | 0.93–1.82 | 0.12 | 1.07 | 0.96–1.21 | 0.22 |